By Ben Hirschler and Kazunori Takada LONDON/SHANGHAI (Reuters) - British drugmaker GlaxoSmithKline said on Monday some of its executives in China appeared to have broken the law in a bribery scandal, as it promised changes in its business model that would lower the cost of medicine in the country. GSK is the latest in a string of multinationals to be targeted by Chinese authorities over alleged corruption, price-fixing and quality controls. Chinese police visited the Shanghai office of another British drugmaker, AstraZeneca, a company spokeswoman said on Monday. ...
Monday, July 22, 2013
Glaxo says executives appear to have broken Chinese law
Glaxo says executives appear to have broken Chinese law
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment